Skip to main content
Journal cover image

The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy?

Publication ,  Journal Article
Gingrich, JR; Paulson, DF
Published in: Surg Oncol Clin N Am
April 1995

Despite a negative metastatic evaluation, up to 100% of patients with high-grade tumors are found to harbor metastatic disease within the pelvic lymph nodes at the time of surgery. This article reviews the literature regarding efforts to refine noninvasive preoperative staging through the use of serum tumor markers, improved radiologic imaging, and histologic analysis of the biopsy specimens. A discussion of the renewed controversy regarding the role of pelvic lymphadenectomy in the management of adenocarcinoma of the prostate follows.

Duke Scholars

Published In

Surg Oncol Clin N Am

ISSN

1055-3207

Publication Date

April 1995

Volume

4

Issue

2

Start / End Page

335 / 344

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Predictive Value of Tests
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Male
  • Lymphatic Metastasis
  • Lymph Node Excision
  • Humans
  • Biomarkers, Tumor
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gingrich, J. R., & Paulson, D. F. (1995). The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy? Surg Oncol Clin N Am, 4(2), 335–344.
Gingrich, J. R., and D. F. Paulson. “The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy?Surg Oncol Clin N Am 4, no. 2 (April 1995): 335–44.
Gingrich JR, Paulson DF. The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy? Surg Oncol Clin N Am. 1995 Apr;4(2):335–44.
Gingrich, J. R., and D. F. Paulson. “The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy?Surg Oncol Clin N Am, vol. 4, no. 2, Apr. 1995, pp. 335–44.
Gingrich JR, Paulson DF. The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy? Surg Oncol Clin N Am. 1995 Apr;4(2):335–344.
Journal cover image

Published In

Surg Oncol Clin N Am

ISSN

1055-3207

Publication Date

April 1995

Volume

4

Issue

2

Start / End Page

335 / 344

Location

United States

Related Subject Headings

  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Predictive Value of Tests
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Male
  • Lymphatic Metastasis
  • Lymph Node Excision
  • Humans
  • Biomarkers, Tumor